Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
暂无分享，去创建一个
M. Rudnicki | J. Oliveira | F. Weidemann | C. Sommer | F. Cecchi | C. Hollak | R. Arngrímsson | A. Serra | E. Svarstad | A. Mehta | C. Hendriksz | U. Ramaswami | N. Karabul | A. Tylki-Szymańska | D. Hughes | G. Sunder-Plassmann | I. Kantola | P. Deegan | T. Geberhiwot | C. Lavery | R. Parini | F. Wijburg | D. Germain | F. Barbey | G. Linthorst | U. Feldt-Rasmussen | C. Tøndel | M. Biegstraaten | P. Woolfson | L. Boks | Erica van de Mheen | Annelies Sweeb | W. Terryn | B. Vujkovac